Research/Scholarly Activities | Pulmonary/Critical Care

Division StatementFaculty | Research/Scholarly Activities | Fellowship 

Scholarship in the Division of Pulmonary Medicine

The mission of our division is to improve the health of our citizens. Our special focus is to engage in clinical, basic and educational research addressing acute and chronic lung conditions and sepsis. Each of our faculty is involved in clinical scholarly activity in their special areas of interest. A pooled bibliography in excess of 150 publications support our division’s research interests. Areas of scholarship of particular interest to the faculty include, but are not limited to:

  • hypersensitivity pneumonitis (Byrd)
  • immunologic diseases of the lung (Byrd)
  • pneumoconiosis (Roy)
  • tuberculosis (Mehta)
  • management of adult respiratory distress syndrome (Byrd, Roy)
  • septic shock (Elgazzar)

Our Faculty and Fellows publish scholarly activity that involves basic research as well as clinical research aimed at improving respiratory clinical care and sleep health. Dr. Elgazzar’s highly productive basic science laboratory focuses on basic molecular processes that can be translated to the field of inflammation, with a focus on severe systemic inflammatory processes like sepsis.

Recent Publications by the Division include:

Abel Nour SM, Mehta JB, Roy TM, Byrd RP, Jr. Veillonella as a cause for septic pulmonary emboli. Tenn.Med. 2013 Nov;106(10):39-40.

Brahmbhatt PA, Modi FD, Roy TM, Byrd RP, Jr. Common carotid artery laceration and innominate artery pseudo-aneurysm following a percutaneous dilatational tracheostomy attempt. Respir.Care 2014 Oct;59(10):e153-e155.

Brudecki L, Ferguson DA, McCall CE, El GM. MicroRNA-146a and RBM4 form a negative feed-forward loop that disrupts cytokine mRNA translation following TLR4 responses in human THP-1 monocytes. Immunol.Cell Biol. 2013 Sep;91(8):532-40.

Brudecki L, Ferguson DA, McCall CE, El GM. Mitogen-activated protein kinase phosphatase 1 disrupts proinflammatory protein synthesis in endotoxin-adapted monocytes. Clin.Vaccine Immunol. 2013 Sep;20(9):1396-404.

Byrd RP, Jr., Roy TM. Spontaneous resolution of a giant pulmonary bulla: what is the role of bronchodilator and anti-inflammatory therapy? Tenn.Med. 2013 Jan;106(1):39-42.

Byrd RP, Jr., Roy TM. Spontaneous resolution of a giant pulmonary bulla: what is the role of bronchodilator and anti-inflammatory therapy? Tenn.Med. 2013 Jan;106(1):39-42.

Chaudhari H, Mehta JB, Chaudhari K, Farrow J. Treatment of cerebral malaria and acute respiratory distress syndrome (ARDS) with parenteral artesunate. Tenn.Med. 2013 May;106(5):41-3.

El GM. microRNAs as potential regulators of myeloid-derived suppressor cell expansion. Innate.Immun. 2014 Apr;20(3):227-38.

McClure C, Brudecki L, Ferguson DA, Yao ZQ, Moorman JP, McCall CE, El GM. MicroRNA 21 (miR-21) and miR-181b couple with NFI-A to generate myeloid-derived suppressor cells and promote immunosuppression in late sepsis. Infect.Immun. 2014 Sep;82(9):3816-25.

Nour SA, Nour HA, Mehta J, Roy T, Byrd R. Tracheobronchial calcification due to warfarin therapy. Am.J.Respir.Crit Care Med. 2014 Jun 15;189(12):e73.

Nour SM, Nour HA, Mehta JB, Roy TM, Byrd RP, Jr. Hemoptysis and respiratory failure following sildenafil use for pulmonary hypertension. Tenn.Med. 2013 Mar;106(3):34-5.

Nour SM, Nour HA, Mehta JB, Roy TM, Byrd RP, Jr. Hemoptysis and respiratory failure following sildenafil use for pulmonary hypertension. Tenn.Med. 2013 Mar;106(3):34-5.

Zaietta GA, Raval AA, Murillo L, Mehta J, Byrd RP, Jr., Roy TM. Case report and review of the literature: spontaneous aortobronchial fistula. Tenn.Med. 2013 Apr;106(4):39-42.